Search research articles
Contact Us
Filters
Showing results (41-50 of 159) with videos related to
Page
of 16
Sort By:
The Oncologist
|
April 5, 2022
Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes
Yunbi Ni, Julia Y Tsang, Yan Shao, et al.
Histopathology
|
March 29, 2026
Calcification and tumour-infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 (HER2)-negative ductal carcinoma in situ diagnosed on core needle biopsy
Monalyn Marabi, Yuyang Li, Chaiwat Aphivatanasiri, et al.
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society
|
April 23, 2025
Ray-Aided Quadruple Affiliation Network for Calculating Tumor-Stroma Ratios in Breast Cancers
Kunping Yang, Linying Chen, Xi Zheng, et al.
Journal of Clinical Pathology
|
June 10, 2015
Associations of epithelial c-kit expression in phyllodes tumours of the breast
John Tawasil, Edna May L Go, Julia Y S Tsang, et al.
Cancer Science
|
April 27, 2012
Pure flat epithelial atypia is uncommon in subsequent breast excisions for atypical epithelial proliferation
Rin Yamaguchi, Maki Tanaka, Gary M Tse, et al.
Annals of Surgical Oncology
|
February 10, 2015
Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast Cancer
Maribel D Lacambra, Julia Y S Tsang, Yun-Bi Ni, et al.
Acta Cytologica
|
December 21, 2023
Cytomorphological Assessment in Aspirates of Ductal Carcinoma in situ: Correlations with Histopathologic Grade, Architectural Pattern, and Invasion
Joshua J X Li, Maria B C Y Chow, Joanna K M Ng, et al.
Annals of Diagnostic Pathology
|
August 14, 2023
Detection of early (T1) lung cancers and lepidic adenocarcinomas in sputum and bronchial cytology
Joanna K M Ng, Wing Cheung, Joshua J X Li, et al.
The American Journal of Surgical Pathology
|
April 16, 2005
Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?
Puay Hoon Tan, Meng Yuan Aw, George Yip, et al.
Oncotarget
|
December 18, 2015
FGFR1 is an adverse outcome indicator for luminal A breast cancers
Yu-Jie Shi, Julia Y S Tsang, Yun-Bi Ni, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 159) with videos related to
Sort By:
Page
of 16
The Oncologist
|
April 5, 2022
Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes
Yunbi Ni, Julia Y Tsang, Yan Shao, et al.
Histopathology
|
March 29, 2026
Calcification and tumour-infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 (HER2)-negative ductal carcinoma in situ diagnosed on core needle biopsy
Monalyn Marabi, Yuyang Li, Chaiwat Aphivatanasiri, et al.
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society
|
April 23, 2025
Ray-Aided Quadruple Affiliation Network for Calculating Tumor-Stroma Ratios in Breast Cancers
Kunping Yang, Linying Chen, Xi Zheng, et al.
Journal of Clinical Pathology
|
June 10, 2015
Associations of epithelial c-kit expression in phyllodes tumours of the breast
John Tawasil, Edna May L Go, Julia Y S Tsang, et al.
Cancer Science
|
April 27, 2012
Pure flat epithelial atypia is uncommon in subsequent breast excisions for atypical epithelial proliferation
Rin Yamaguchi, Maki Tanaka, Gary M Tse, et al.
Annals of Surgical Oncology
|
February 10, 2015
Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast Cancer
Maribel D Lacambra, Julia Y S Tsang, Yun-Bi Ni, et al.
Acta Cytologica
|
December 21, 2023
Cytomorphological Assessment in Aspirates of Ductal Carcinoma in situ: Correlations with Histopathologic Grade, Architectural Pattern, and Invasion
Joshua J X Li, Maria B C Y Chow, Joanna K M Ng, et al.
Annals of Diagnostic Pathology
|
August 14, 2023
Detection of early (T1) lung cancers and lepidic adenocarcinomas in sputum and bronchial cytology
Joanna K M Ng, Wing Cheung, Joshua J X Li, et al.
The American Journal of Surgical Pathology
|
April 16, 2005
Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?
Puay Hoon Tan, Meng Yuan Aw, George Yip, et al.
Oncotarget
|
December 18, 2015
FGFR1 is an adverse outcome indicator for luminal A breast cancers
Yu-Jie Shi, Julia Y S Tsang, Yun-Bi Ni, et al.
Page
of 16